Literature DB >> 2225701

Caffeine and theophylline attenuate adenosine-induced vasodilation in humans.

P Smits1, J W Lenders, T Thien.   

Abstract

In this study the local vasoactive effects of adenosine were explored in the human forearm. Adenosine (15 micrograms/100 ml forearm/min) infused into the brachial artery (n = 6) increased forearm blood flow by 572% +/- 140%, versus - 0.5% +/- 5.8% during placebo infusion (p less than 0.01). Lower adenosine infusion rates (5 micrograms/100 ml forearm/min, three times) induced forearm blood flow increments to 330% +/- 94%, 339% +/- 67% and 330% +/- 79%, respectively (n = 8). These forearm blood flow responses were reduced (p = 0.02) during concomitant intra-arterial infusion of two doses of caffeine (30 and 90 micrograms/100 ml forearm/min) to 150% +/- 45% and 98% +/- 28%, respectively. Theophylline (30 micrograms/100 ml forearm/min; n = 6) also significantly attenuated the adenosine-induced increase in forearm blood flow. Enprofylline (30 micrograms/100 ml forearm/min), a related xanthine with a low affinity to adenosine receptors in vitro, did not change the response to adenosine. Nonspecific vasodilation by sodium nitroprusside infusion (50 ng/100 ml forearm/min) was not inhibited by caffeine compared with placebo (forearm blood flow responses were 202% +/- 21% versus 216% +/- 40%; n = 6). This study demonstrated that caffeine and theophylline specifically reduce adenosine-induced vasodilation in humans, supporting the existence of functional human vascular adenosine receptors.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2225701     DOI: 10.1038/clpt.1990.169

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  27 in total

1.  Effect of caffeine on neonatal splanchnic blood flow.

Authors:  A J Lane; R C Coombs; D H Evans; R J Levin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

2.  Procedure guidelines for radionuclide myocardial perfusion imaging.

Authors:  C Anagnostopoulos; M Harbinson; A Kelion; K Kundley; C Y Loong; A Notghi; E Reyes; W Tindale; S R Underwood
Journal:  Heart       Date:  2004-01       Impact factor: 5.994

Review 3.  The impact of caffeine on vasodilator stress perfusion studies.

Authors:  Andre C Lapeyre; Tauqir Y Goraya; Donald L Johnston; Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

4.  The effect of caffeine on glucose kinetics in humans--influence of adrenaline.

Authors:  Danielle S Battram; Terry E Graham; Erik A Richter; Flemming Dela
Journal:  J Physiol       Date:  2005-09-08       Impact factor: 5.182

5.  Effects of a divided high loading dose of caffeine on circulatory variables in preterm infants.

Authors:  C Hoecker; M Nelle; B Beedgen; J Rengelshausen; O Linderkamp
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-01       Impact factor: 5.747

Review 6.  Practicing safe SPECT: caffeine abstinence in nuclear myocardial perfusion imaging.

Authors:  Kristina E Powles; Renee C Hessian; Terrence D Ruddy
Journal:  J Nucl Cardiol       Date:  2008 Sep-Oct       Impact factor: 5.952

7.  Methotrexate modulates the kinetics of adenosine in humans in vivo.

Authors:  N P Riksen; P Barrera; P H H van den Broek; P L C M van Riel; P Smits; G A Rongen
Journal:  Ann Rheum Dis       Date:  2005-11-24       Impact factor: 19.103

8.  Coronary flow reserve is supranormal in endurance athletes: an adenosine transthoracic echocardiographic study.

Authors:  D J Hildick-Smith; P J Johnson; C R Wisbey; E M Winter; L M Shapiro
Journal:  Heart       Date:  2000-10       Impact factor: 5.994

9.  Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine.

Authors:  G A Rongen; S C Brooks; S i Ando; B L Abramson; J S Floras
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

10.  Role of adenosine in the sympathetic activation produced by isometric exercise in humans.

Authors:  F Costa; I Biaggioni
Journal:  J Clin Invest       Date:  1994-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.